Results 131 to 140 of about 11,219 (248)

Вивчення якості життя та тривожності у хворих на міастенію (клініко-параклінічні співставлення) [PDF]

, 2018
У статті представлено результати дослідження тривожності та якості життя у 96 хворих на міастенію в залежності від імунологічного типу, тривалості та клінічної форми захворювання.
Кальбус, О.І.
core  

Dynamic Parameters within the First 72 H of ICU Admission Predict Extubation Failure and 28‐Day Mortality in Severe Pneumonia‐Induced ARDS: A Retrospective Cohort Study

The Clinical Respiratory Journal, Volume 20, Issue 5, May 2026.
Early 72‐h dynamic changes in key physiological and laboratory parameters predict extubation failure and 28‐day mortality in severe pneumonia‐induced ARDS. Extubation failure is strongly associated with increased mortality, highlighting the clinical value of dynamic monitoring for early risk stratification in ICU patients.
Chen Wang, Yalong Liu, Wenqing Xu, Hanhan Hong   +3 more
wiley   +1 more source

Barnes Hospital Bulletin [PDF]

, 1981
https://digitalcommons.wustl.edu/bjc_barnes_bulletin/1188/thumbnail ...

core   +1 more source

Bispecific Dual‐Immune Checkpoint Inhibitor Associated Cutaneous Toxicity: A Report of Lorigerlimab Adverse Skin Reaction in Two Cancer Patients

Journal of Cutaneous Pathology, Volume 53, Issue 5, Page 422-426, May 2026.
ABSTRACT Lorigerlimab is a dual bispecific antibody (BsAb) targeting cytotoxic T‐lymphocyte‐associated protein 4 and programmed cell death protein 1 that is used for treatment of advanced solid cancers such as metastatic castration‐resistant prostate carcinoma.
Niloofar Sina, Fiorinda Muhaj, Volha Lenskaya, Doina Ivan, Victor G. Prieto, Jonathan L. Curry   +5 more
wiley   +1 more source

Evaluation of Sustained Disease Control With Nipocalimab Versus Placebo in the Phase 3 Vivacity‐MG3 Study

European Journal of Neurology, Volume 33, Issue 5, May 2026.
In the Vivacity‐MG3 study, clinical response to nipocalimab was assessed using the MG‐ADL and QMG measures. Nipocalimab treatment improves gMG symptoms earlier than placebo and provides sustained disease control over the 24‐week double‐blind period.
Tuan Vu, Said R. Beydoun, Richard J. Nowak, Hans Katzberg, Maria Ait‐Tihyaty, Kavita Gandhi, John J. Sheehan, Sheryl Pease, Ibrahim Turkoz, Bernie Sattin, Zia Choudhry, Sindhu Ramchandren, Carlo Antozzi   +12 more
wiley   +1 more source

Real‐World Occurrence of Adverse Events Associated With Adjuvant Pembrolizumab Therapy for Renal Cell Carcinoma: A Multicenter Retrospective Study

International Journal of Urology, Volume 33, Issue 5, May 2026.
ABSTRACT Background Pembrolizumab is indicated as adjuvant therapy after nephrectomy in patients with high‐risk renal cell carcinoma (RCC). However, data regarding the occurrence of treatment‐related adverse events (TRAEs) associated with pembrolizumab in real‐world clinical settings in Japanese patients remain limited.
Koji Iinuma, Kohei Nishikawa, Yuta Sano, Kaori Ozawa, Toyohiro Yamada, Tomoki Taniguchi, Keita Nakane, Takahiro Inoue, Shusuke Akamatsu, Takuya Koie   +9 more
wiley   +1 more source

Two‐decade battle with myasthenia gravis: A breakthrough case report on the long‐term success with eculizumab and ravulizumab treatment

Clinical Case Reports
Key Clinical Message This unique case of generalized myasthenia gravis shows sustained stability of a patient's condition for 3 years with eculizumab/ravulizumab treatment following 16 years of refractory disease.
Stefan Quasthoff
doaj   +1 more source

Real-world experience with efgartigimod in generalized myasthenia gravis: a single-center retrospective study in China

Frontiers in Immunology
ObjectiveThis study aimed to evaluate the real-world efficacy, safety, and application patterns of efgartigimod in Chinese patients with generalized myasthenia gravis (gMG), with a focus on individualized treatment strategies.MethodsWe conducted a single-
Zhenyu Niu, Jianchun Wang, Jingru Ren, Ran Liu, Jing Guo, Nan Zhang, Yiming Zheng, Hongjun Hao, Feng Gao, Haiqiang Jin   +9 more
doaj   +1 more source

Ectopic cervical thymoma in myasthenia gravis: a case report

BMC Neurology
Background Ectopic cervical thymoma (ECT) is an extremely rare tumor, especially in association with myasthenia gravis (MG). Case presentation We report a case of myasthenia gravis with an ectopic thymoma in the neck, whose myasthenic symptoms ...
Shima Zargar, Maryam Hosseini Farahabadi, Samuel J. Reynolds   +2 more
doaj   +1 more source

Spectrum of neurological disorders presenting at a neurology clinic in tertiary care hospital in peshawar, pakistan [PDF]

, 2015
To ascertain the spectrum of different neurological disorders presenting at a tertiary care neurology clinic in Peshawar, Pakistan. Method: A prospective observational study was conducted of all presentations to the neurology clinic in Northwest General ...
Khan, Haroon, M. Alam, Sardar, Wahid, Khatira   +2 more
core   +1 more source